Amoebic liver abscess — DTM&H MCQ

Correct answer: B — If there is no clinical improvement after 48-72 hours of metronidazole

The correct answer is B, if there is no clinical improvement after 48-72 hours of metronidazole. Amoebic liver abscess responds rapidly to metronidazole in the vast majority of cases, and this response is itself a diagnostic clue distinguishing it from pyogenic abscess. A published conservative management policy showed that percutaneous ultrasound-guided aspiration is only needed in the minority who fail to improve, and that this failure to respond should trigger drainage rather than fixed anatomical criteria. Persistent fever or pain beyond 72 hours raises concern for an incorrect diagnosis, secondary bacterial superinfection, or impending rupture, all of which are indications for intervention. First-line management therefore remains medical, with drainage reserved as a rescue strategy for non-responders. Why the other options are wrong: E. If the abscess exceeds 5 cm diameter: size alone (including this 10 cm abscess) is not an indication for drainage when the patient is responding clinically to metronidazole; large abscesses can and do resolve on antiamoebic therapy alone. C. In all cases for definitive microbiological diagnosis: aspiration is not routinely required once serology and clinical/radiological features are consistent with amoebic disease; it is reserved for diagnostic uncertainty (for example, suspicion of pyogenic abscess) or treatment failure, not performed universally. D. If the abscess is in the right lobe: right lobe location is the typical site for amoebic abscesses and is not itself a complication or an indication for intervention. A. If serology titres exceed a threshold value: serology confirms exposure and supports diagnosis but titres do not correlate with abscess severity, rupture risk, or need for drainage, and there is no validated threshold used to trigger aspiration. Key point: Amoebic liver abscess is managed medically first, with percutaneous drainage reserved for clinical non-response to metronidazole at 48 to 72 hours, not for size, laterality, or serology values alone.

Reference: Percutaneous ultrasound-guided aspiration is indicated only in patients who fail to improve clinically after 48-72 hours of metronidazole (Amoebic liver abscess: results of a conservative management policy, PubMed 12640885); consistent with UK tropical medicine teaching (DTM&H) and Manson's Tropical Diseases guidance on amoebiasis management.